Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence

Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence

The purpose of this study is to determine whether anorectal application of Nasha Dx is safe and effective for treatment of anal incontinence.

Patients not fully improved after 1:st injection were offered reinjection after 4-6 weeks.

Inclusion Criteria:

• Incontinence to loose or solid stool at least once weekly (Millers incontinence score 6-12).
• Age 18-80
• Available for follow-up for the duration of the study
• Written informed consent.

Exclusion Criteria:

• Sphincter defect visible on anal ultrasound.
• Pregnancy.
• Rectal prolapse or inflammatory bowel disease.
• Recent (within 6 months) anal surgery except for haemorrhoids.
• Anorectal sepsis.
• Anticoagulant medication or bleeding diathesis.